Core Viewpoint - The company has decided not to exercise the right to adjust the conversion price of its convertible bonds, "Xianle Convertible Bonds," despite meeting the conditions for downward adjustment, in order to protect the interests of all investors [10]. Group 1: Convertible Bond Issuance - The company issued 10.2489 million convertible bonds with a total fundraising amount of RMB 1,024.8929 million, netting RMB 1,016.1675 million after expenses [1]. - The bonds were listed on the Shenzhen Stock Exchange on May 14, 2021, under the name "Xianle Convertible Bonds" and code "123113" [2]. - The conversion period for the bonds began on October 25, 2021, following the end of the bond issuance [2]. Group 2: Conversion Price Adjustment - The conversion price was initially set at RMB 85.98 per share and was adjusted to RMB 56.92 per share after a cash dividend and capital increase [2][3]. - Subsequent adjustments to the conversion price occurred on several occasions, with the latest adjustment reducing the price to RMB 31.82 per share effective May 27, 2025 [8]. - The company has the authority to propose a downward adjustment of the conversion price if the stock price falls below 85% of the conversion price for at least 15 trading days within a 30-day period [9]. Group 3: Board Decisions - The company's board of directors convened on July 30, 2025, and decided not to propose a downward adjustment of the conversion price for the next six months, even if the conditions for adjustment are met again [10]. - This decision was made to maintain investor confidence and protect the interests of all stakeholders [10].

Group 1 - The core point of the article is that Xianle Health announced it will not exercise the downward adjustment of the conversion price for its convertible bonds, despite triggering the conditions for such an adjustment [2] - As of July 30, 2025, the company's stock has been below 85% of the conversion price for at least 15 out of the last 30 trading days, triggering the downward adjustment clause for the Xianle convertible bonds [2] - The company's board of directors decided not to propose a downward adjustment plan for the next six months, from July 31, 2025, to January 30, 2026, even if the conditions are triggered again [2]

Group 1 - The core viewpoint of the article discusses recent developments in the Chinese stock market, particularly focusing on new stock listings and convertible bonds [1] - The new stock "Youli Intelligent" on the Beijing Stock Exchange has a threshold of 6.47 million [1] - The "Lincang Convertible Bond" is undergoing a down adjustment [1] - The "Gansu Energy Chemical" has resumed production at its Wangjiashan Coal Mine, well number one [1] - The "Aofei Convertible Bond" will not be forcibly redeemed [1] - "Dongjie Intelligent" is undergoing changes in its controlling shareholder's upper-level equity structure, which may lead to a change in the actual controller [1] - The "Xianle Convertible Bond," "Shengxun Convertible Bond," and "Jingrui Convertible Bond 2" will not undergo down adjustments [1] - "Dingjia Precision" has been listed as a new stock on the Beijing Stock Exchange [1]

Core Viewpoint - The company is expected to trigger the downward adjustment of the conversion price for its convertible bonds due to the stock closing price being below 85% of the current conversion price, which is set at 27.10 CNY per share [12]. Summary by Sections Convertible Bond Issuance Overview - The company issued 10,248,900 convertible bonds with a face value of 100 CNY each, raising a total of 1,024.89 million CNY, with a net amount of 1,016.17 million CNY after deducting issuance costs [1]. - The bonds were approved by the China Securities Regulatory Commission and began trading on May 14, 2021, under the name "Xianle Convertible Bonds" with the code "123113" [2]. Conversion Period and Price Adjustment - The conversion period for the bonds started on October 25, 2021, which is six months after the issuance [2]. - The conversion price has been adjusted multiple times due to various corporate actions, including cash dividends and stock grants, with the latest adjustment on June 7, 2023, changing the price from 56.42 CNY to 56.07 CNY [6]. Downward Adjustment Conditions - The company has the authority to propose a downward adjustment of the conversion price if the stock price is below 85% of the conversion price for at least 15 out of 30 consecutive trading days [11]. - If the adjustment condition is met, the board will convene to decide on the adjustment and disclose the decision promptly [12]. Recent Stock Performance - From July 10 to July 23, 2025, the company's stock has closed below the threshold for the conversion price adjustment, indicating a potential trigger for the downward adjustment [12].

Core Points - The company, Xianle Health Technology Co., Ltd., will soon announce the implementation of the 2024 equity distribution, which will affect the convertible bonds [1] - The convertible bonds (code: 123113; abbreviation: Xianle Convertible Bonds) will suspend conversion from May 13, 2025, until the equity registration date for the 2024 distribution, resuming on the first trading day after the registration [1] - The company assures that the information disclosed is true, accurate, and complete, with no false records or misleading statements [1] Summary by Sections - **Convertible Bond Adjustment**: The adjustment of the conversion price for the convertible bonds will occur in the event of stock dividends, capital increases, new share issuances, rights issues, or cash dividends, with specific formulas provided for each scenario [1][2] - **Price Adjustment Mechanism**: The formulas for adjusting the conversion price are detailed, including variables such as the previous conversion price (P0), stock dividend rate (n), new share issuance rate (k), new share price (A), and cash dividend per share (D) [1][2] - **Disclosure of Adjustments**: The company will publish announcements regarding the adjustment of the conversion price in designated media, including the adjustment date, method, and any suspension of conversion [2]

Core Points - The company announced an adjustment to the conversion price of its convertible bonds, reducing it from RMB 42.13 per share to RMB 41.96 per share, effective from March 28, 2025 [1][8] - The adjustment is based on the issuance of new shares and follows the formula outlined in the company's prospectus, which considers the price of new shares and the rate of issuance [1][8] Summary by Sections Conversion Price Adjustment - The previous conversion price was RMB 42.13 per share, which has been adjusted to RMB 41.96 per share [1][8] - The adjustment is triggered by the issuance of new shares under the company's stock incentive plan, which increased the total share capital by 1,401,000 shares, representing a 0.59% increase [5][8] Basis for Adjustment - The adjustment follows the formula: P1 = (P0 + A × k) / (1 + k), where P0 is the previous conversion price, A is the new share price, and k is the issuance rate [1][8] - The new share price for the incentive plan is set at RMB 13.27 per share [5][8] Previous Adjustments - The conversion price has undergone several adjustments in the past due to various corporate actions, including cash distributions and stock grants, with the most recent adjustment prior to this being on June 7, 2023, when it was set at RMB 56.07 per share [4][6][8]